gastric cancer

You have access
Prognostic Significance of HER2 Expression for Gastric Cancer With Clinically Para-aortic Lymph Node Metastasis
TAKAAKI ARIGAMI, DAISUKE MATSUSHITA, KEISHI OKUBO, KEN SASAKI, YUSUKE TSURUDA, YOSHIAKI KITA, SHINICHIRO MORI, SHIGEHIRO YANAGITA, YOSHIKAZU UENOSONO, HIROSHI KURAHARA and TAKAO OHTSUKA

Anticancer Research June 2021, 41 (6) 3099-3107; DOI: https://doi.org/10.21873/anticanres.15094
You have access
Alpha-fetoprotein for Gastric Cancer Staging: An Essential or Redundant Tumor Marker?
CHUN-YI TSAI, KENG-HAO LIU, CHENG-TANG CHIU, SHUN-WEN HSUEH, CHIA-YEN HUNG, JUN-TE HSU, NGAN-MING TSANG, YU-SHIN HUNG and WEN-CHI CHOU

Anticancer Research May 2021, 41 (5) 2711-2718; DOI: https://doi.org/10.21873/anticanres.15052
You have access
MiR-3663-3p Inhibits the Progression of Gastric Cancer Through the CCND1 Pathway
KOJI TAKAO, HIROTAKA KONISHI, DAIKI MATSUBARA, KATSUTOSHI SHODA, TOMOHIRO ARITA, HIROKI SHIMIZU, SHUHEI KOMATSU, ATSUSHI SHIOZAKI, YUSUKE YAMAMOTO, TAKESHI KUBOTA, HITOSHI FUJIWARA, KAZUMA OKAMOTO and EIGO OTSUJI

Anticancer Research May 2021, 41 (5) 2441-2449; DOI: https://doi.org/10.21873/anticanres.15019
Open Access
Clinical Impact of Perioperative Oral Nutritional Treatment for Body Composition Changes in Gastrointestinal Cancer Treatment
TORU AOYAMA, MASATO NAKAZONO, SHINNOSUKE NAGASAWA and KENKI SEGAMI

Anticancer Research April 2021, 41 (4) 1727-1732; DOI: https://doi.org/10.21873/anticanres.14937
You have access
Peroxiredoxin V Silencing Elevates Susceptibility to Doxorubicin-induced Cell Apoptosis via ROS-dependent Mitochondrial Dysfunction in AGS Gastric Cancer Cells
YONG-ZHE JIN, YI-XI GONG, YUE LIU, DAN-PING XIE, CHEN-XI REN, SEUNG-JAE LEE, HU-NAN SUN, TAEHO KWON and DONG-YUAN XU

Anticancer Research April 2021, 41 (4) 1831-1840; DOI: https://doi.org/10.21873/anticanres.14949
You have access
MDM4 as a Prognostic Factor for Patients With Gastric Cancer With Low Expression of p53
XIAOCHEN ZHANG, YOSHIYUKI YAMAMOTO, XIAOXUAN WANG, MASASHI SATO, MAMIKO IMANISHI, AKINORI SUGAYA, MITSUAKI HIROSE, SHINJI ENDO, TOSHIKAZU MORIWAKI, KENJI YAMATO and ICHINOSUKE HYODO

Anticancer Research March 2021, 41 (3) 1475-1483; DOI: https://doi.org/10.21873/anticanres.14906
You have access
Prognostic Factors for Gastric Cancer Patients With One Stage IV Factor who Underwent Conversion Surgery
YOTA SHIMODA, HIROHITO FUJIKAWA, KEISUKE KOMORI, HAYATO WATANABE, KAZUKI KANO, TAKANOBU YAMADA, MANABU SHIOZAWA, SOICHIRO MORINAGA, KENJI KATSUMATA, AKIHIKO TSUCHIDA, TAKASHI OGATA and TAKASHI OSHIMA

Anticancer Research February 2021, 41 (2) 1005-1012; DOI: https://doi.org/10.21873/anticanres.14855
You have access
Tissue RNFT2 Expression Levels Are Associated With Peritoneal Recurrence and Poor Prognosis in Gastric Cancer
MASAHIRO SASAHARA, MITSURO KANDA, DAI SHIMIZU, CHIE TANAKA, YOSHIKUNI INOKAWA, NORIFUMI HATTORI, MASAMICHI HAYASHI, GORO NAKAYAMA and YASUHIRO KODERA

Anticancer Research February 2021, 41 (2) 609-617; DOI: https://doi.org/10.21873/anticanres.14812
You have access
Prediction Model for Gastric Cancer With DNA Mismatch Repair Deficiency
OKIHIDE SUZUKI, TATSURO YAMAGUCHI, MINORU FUKUCHI, ERITO MOCHIKI, TOMIO ARAI, KIWAMU AKAGI and HIDEYUKI ISHIDA

Anticancer Research February 2021, 41 (2) 975-982; DOI: https://doi.org/10.21873/anticanres.14851
You have access
Extracellular Acidity-mediated Expression of cPLA2γ Confers Resistance in Gastric Cancer Cells
SUNG-CHUL LIM, TAE-BUM LEE, BYUNG-SOO KANG and SONG IY HAN

Anticancer Research January 2021, 41 (1) 211-218; DOI: https://doi.org/10.21873/anticanres.14767

Main menu

User menu

Search

gastric cancer

Pages